Gallagher, Jason C., Conan MacDougall, Elizabeth S Dodds Ashley, and John R. Perfect. “Recent advances in antifungal pharmacotherapy for invasive fungal infections.” Expert Rev Anti Infect Ther 2, no. 2 (April 2004): 253–68. https://doi.org/10.1586/14787210.2.2.253.
Lodge, Barbara Alexander, Elizabeth Dodds Ashley, Mark P. Steele, and John R. Perfect. “Aspergillus fumigatus empyema, arthritis, and calcaneal osteomyelitis in a lung transplant patient successfully treated with posaconazole.” J Clin Microbiol 42, no. 3 (March 2004): 1376–78. https://doi.org/10.1128/JCM.42.3.1376-1378.2004.
Drew, Richard H., Elizabeth Dodds Ashley, Daniel K. Benjamin, R. Duane Davis, Scott M. Palmer, and John R. Perfect. “Comparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung-transplant recipients.” Transplantation 77, no. 2 (January 27, 2004): 232–37. https://doi.org/10.1097/01.TP.0000101516.08327.A9.
Drew, R. H., M. D. Johnson, E. D. Ashley, and J. R. Perfect. “Rational use of antifungals for invasive fungal infections in the institutional setting.” In Antibiotic Optimization: Concepts and Strategies in Clinical Practice, 577–644, 2004.
Gallagher, Jason C., Elizabeth S. Dodds Ashley, Richard H. Drew, and John R. Perfect. “Antifungal pharmacotherapy for invasive mould infections.” Expert Opin Pharmacother 4, no. 2 (February 2003): 147–64. https://doi.org/10.1517/14656566.4.2.147.
Dodds Ashley, E. S., K. Kirk, and V. G. Fowler. “Patient detection of a drug dispensing error by use of physician-provided drug samples.” Pharmacotherapy 22, no. 12 I (December 1, 2002): 1642–43. https://doi.org/10.1592/phco.22.17.1642.34123.
Dodds, E. S., D. B. May, and R. H. Drew. “Recent changes in vaccination guidelines. An update on vaccines and target population initiatives.” N C Med J 61, no. 6 (November 2000): 326–32.